Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119371463 | 11937146 | 3 | F | 20150904 | 20160711 | 20160121 | 20160714 | EXP | PHJP2016JP001269 | NOVARTIS | 10.00 | YR | F | Y | 0.00000 | 20160714 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119371463 | 11937146 | 1 | PS | NEORAL | CYCLOSPORINE | 1 | Oral | 100 MG, QD | Y | U | UNK | 50715 | 100 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119371463 | 11937146 | 1 | Focal segmental glomerulosclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119371463 | 11937146 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119371463 | 11937146 | Headache | |
| 119371463 | 11937146 | Product use issue | |
| 119371463 | 11937146 | Reversible cerebral vasoconstriction syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119371463 | 11937146 | 1 | 20150904 | 0 |